Search

Your search keyword '"Andersen, Mads Hald"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Andersen, Mads Hald" Remove constraint Author: "Andersen, Mads Hald" Publisher elsevier Remove constraint Publisher: elsevier
17 results on '"Andersen, Mads Hald"'

Search Results

2. The choriocarcinoma cell line JEG-3 upregulates regulatory T cell phenotypes and modulates pro-inflammatory cytokines through HLA-G.

3. Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.

4. Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab.

5. The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma.

6. A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles.

7. Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures.

8. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.

9. Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.

10. Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56.

11. Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709).

12. Cytotoxic T cells.

13. Immunogenicity of Bcl-2 in patients with cancer.

15. The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses.

16. Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.

17. Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.

Catalog

Books, media, physical & digital resources